Literature DB >> 1700279

Receptor functions and ligand-dependent transforming potential of a chimeric kit proto-oncogene.

S Lev1, Y Yarden, D Givol.   

Abstract

The c-kit proto-oncogene, the cellular homolog of the transforming gene of a feline retrovirus, encodes a transmembrane tyrosine kinase homologous to receptors for growth factors. To study the cellular function of c-kit, we constructed a chimeric molecule composed of the extracellular portion of the receptor for epidermal growth factor (EGF) and the transmembrane and cytoplasmic domains of p145kit. The hybrid molecule was properly expressed in murine fibroblasts and displayed specific binding of EGF (Kd, 3 x 10(-8) M). Activation of the chimeric receptor by EGF stimulated the tyrosine kinase activity of kit and led to the generation of a potent mitogenic signal. Moreover, cells expressing the chimeric receptor acquired a transformed phenotype once they were stimulated with the heterologous ligand.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700279      PMCID: PMC361407          DOI: 10.1128/mcb.10.11.6064-6068.1990

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  27 in total

1.  c-kit protein, a transmembrane kinase: identification in tissues and characterization.

Authors:  S Majumder; K Brown; F H Qiu; P Besmer
Journal:  Mol Cell Biol       Date:  1988-11       Impact factor: 4.272

2.  Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes.

Authors:  H Land; L F Parada; R A Weinberg
Journal:  Nature       Date:  1983 Aug 18-24       Impact factor: 49.962

3.  Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice--evidence for an impaired c-kit kinase in mutant mice.

Authors:  K Nocka; S Majumder; B Chabot; P Ray; M Cervone; A Bernstein; P Besmer
Journal:  Genes Dev       Date:  1989-06       Impact factor: 11.361

4.  Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells.

Authors:  P P Di Fiore; J H Pierce; T P Fleming; R Hazan; A Ullrich; C R King; J Schlessinger; S A Aaronson
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

5.  Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene.

Authors:  T J Velu; L Beguinot; W C Vass; M C Willingham; G T Merlino; I Pastan; D R Lowy
Journal:  Science       Date:  1987-12-04       Impact factor: 47.728

6.  Epidermal growth factor binding induces a conformational change in the external domain of its receptor.

Authors:  C Greenfield; I Hiles; M D Waterfield; M Federwisch; A Wollmer; T L Blundell; N McDonald
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

7.  Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.

Authors:  Y Yarden; W J Kuang; T Yang-Feng; L Coussens; S Munemitsu; T J Dull; E Chen; J Schlessinger; U Francke; A Ullrich
Journal:  EMBO J       Date:  1987-11       Impact factor: 11.598

8.  HER2 cytoplasmic domain generates normal mitogenic and transforming signals in a chimeric receptor.

Authors:  J Lee; T J Dull; I Lax; J Schlessinger; A Ullrich
Journal:  EMBO J       Date:  1989-01       Impact factor: 11.598

9.  A chimeric EGF-R-neu proto-oncogene allows EGF to regulate neu tyrosine kinase and cell transformation.

Authors:  H Lehväslaiho; L Lehtola; L Sistonen; K Alitalo
Journal:  EMBO J       Date:  1989-01       Impact factor: 11.598

10.  Differential signalling potential of insulin- and IGF-1-receptor cytoplasmic domains.

Authors:  R Lammers; A Gray; J Schlessinger; A Ullrich
Journal:  EMBO J       Date:  1989-05       Impact factor: 11.598

View more
  15 in total

1.  Interkinase domain of kit contains the binding site for phosphatidylinositol 3' kinase.

Authors:  S Lev; D Givol; Y Yarden
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

2.  Biological and biochemical activities of a chimeric epidermal growth factor-Elk receptor tyrosine kinase.

Authors:  V Lhoták; T Pawson
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

3.  Mitogenic signals and transforming potential of Nyk, a newly identified neural cell adhesion molecule-related receptor tyrosine kinase.

Authors:  L Ling; H J Kung
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

4.  Spontaneous malignant transformation of melanocytes explanted from Wf/Wf mice with a Kit kinase-domain mutation.

Authors:  L Larue; N Dougherty; S Porter; B Mintz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

5.  Mitogenic signalling and substrate specificity of the Flk2/Flt3 receptor tyrosine kinase in fibroblasts and interleukin 3-dependent hematopoietic cells.

Authors:  M Dosil; S Wang; I R Lemischka
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

6.  Heparin-dependent binding and autophosphorylation of epidermal growth factor (EGF) receptor by heparin-binding EGF-like growth factor but not by EGF.

Authors:  D Aviezer; A Yayon
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

7.  Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cells.

Authors:  Ashlee V Moses; Michael A Jarvis; Camilo Raggo; Yolanda C Bell; Rebecca Ruhl; B G Mattias Luukkonen; Diana J Griffith; Cecily L Wait; Brian J Druker; Michael C Heinrich; Jay A Nelson; Klaus Früh
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

8.  c-Kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas.

Authors:  Y Funasaka; T Boulton; M Cobb; Y Yarden; B Fan; S D Lyman; D E Williams; D M Anderson; R Zakut; Y Mishima
Journal:  Mol Biol Cell       Date:  1992-02       Impact factor: 4.138

9.  Transforming properties and substrate specificities of the protein tyrosine kinase oncogenes ros and src and their recombinants.

Authors:  S M Jong; C S Zong; T Dorai; L H Wang
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

Review 10.  Growth factors and tyrosine protein kinases in normal and malignant melanocytes.

Authors:  R Halaban
Journal:  Cancer Metastasis Rev       Date:  1991-06       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.